Current Trends in Corporate Social Responsibility in the Pharmaceutical Industry

Název práce: Current Trends in Corporate Social Responsibility in the Pharmaceutical Industry
Autor(ka) práce: Berezovskaya, Maria
Typ práce: Diploma thesis
Vedoucí práce: Cook, Gina
Oponenti práce: Lhotáková, Markéta
Jazyk práce: English
Abstrakt:
Abstract: The main purpose of this academic work is to study how Corporate Social Responsibility (CSR) is incorporated in companies in pharmaceutical industry, with emphasis on the interaction between the enterprise and the community. The goal is to understand what benefits may this collaboration bring in the long-term. In order to fulfil these objectives, a study case was built based on GlaxoSmithKline Plc., which has been using these practices and has a valuable impact in the countries it is present in. The study insists on the necessity of seeing CSR as a part of any successful business strategy involving all members of the value chain. Patient is the one who benefits the most from CSR activities in pharmaceutical industry, and patient is the one who pays and talks.
Klíčová slova: CSR; pharmaceutical industry; GlaxoSmithKline
Název práce: Current Trends in Corporate Social Responsibility in the Pharmaceutical Industry
Autor(ka) práce: Berezovskaya, Maria
Typ práce: Diplomová práce
Vedoucí práce: Cook, Gina
Oponenti práce: Lhotáková, Markéta
Jazyk práce: English
Abstrakt:
Abstract: The main purpose of this academic work is to study how Corporate Social Responsibility (CSR) is incorporated in companies in pharmaceutical industry, with emphasis on the interaction between the enterprise and the community. The goal is to understand what benefits may this collaboration bring in the long-term. In order to fulfil these objectives, a study case was built based on GlaxoSmithKline Plc., which has been using these practices and has a valuable impact in the countries it is present in. The study insists on the necessity of seeing CSR as a part of any successful business strategy involving all members of the value chain. Patient is the one who benefits the most from CSR activities in pharmaceutical industry, and patient is the one who pays and talks.
Klíčová slova: CSR; Pharma; GlaxoSmithKline

Informace o studiu

Studijní program / obor: Ekonomika a management/International Management
Typ studijního programu: Magisterský studijní program
Přidělovaná hodnost: Ing.
Instituce přidělující hodnost: Vysoká škola ekonomická v Praze
Fakulta: Fakulta mezinárodních vztahů
Katedra: Katedra mezinárodního podnikání

Informace o odevzdání a obhajobě

Datum zadání práce: 25. 2. 2015
Datum podání práce: 31. 5. 2015
Datum obhajoby: 16. 6. 2015
Identifikátor v systému InSIS: https://insis.vse.cz/zp/51592/podrobnosti

Soubory ke stažení

    Poslední aktualizace: